Gender-Equity Model for Liver Allocation Using Artificial Intelligence (GEMA-AI) for Waiting List Liver Transplant Prioritization
Clinical Gastroenterology and Hepatology · 2025-11 · 23 (12) · 2187-2196
DOI: 10.1016/j.cgh.2024.12.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025-11. Verfasst von Antonio Manuel Gómez-Orellana und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science and Numerical Analysis, University of Córdoba, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córd…. Hauptthemen laut MEDLINE: Waiting Lists, Liver Transplantation, Artificial Intelligence, End Stage Liver Disease. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Agencia Estatal de Investigación, European Regional Development Fund.
Abstract (Originalsprache)
BACKGROUND & AIMS: We aimed to develop and validate an artificial intelligence score (gender-equity model for liver allocation using artificial intelligence [GEMA-AI]) to predict liver transplantation (LT) waiting list outcomes using the same input variables contained in existing models. METHODS: This was a cohort study including adult LT candidates enlisted in the United Kingdom (2010-2020) for model training and internal validation and in Australia (1998-2020) for external validation. GEMA-AI combined international normalized ratio, bilirubin, sodium, and the Royal Free Hospital glomerular filtration rate in an explainable artificial neural network. GEMA-AI was compared with gender-equity model for liver allocation corrected by serum sodium (GEMA-Na), Model for End-Stage Liver Disease 3.0, and Model for End-Stage Liver Disease corrected by serum sodium for waiting list prioritization. RESULTS: The study included 9320 patients: 5762 in the training cohort, 1920 in the internal validation cohort, and 1638 in the external validation cohort. The prevalence of 90-day mortality or delisting for sickness ranged from 5.3% to 6% across different cohorts. GEMA-AI showed better discrimination than GEMA-Na, Model for End-Stage Liver Disease corrected by serum sodium, and Model for End-Stage Liver Disease 3.0 in the internal and external validation cohorts, with a more pronounced benefit in women and in patients showing at least 1 extreme analytical value. Accounting for identical input variables, the transition from a linear to a nonlinear score (from GEMA-Na to GEMA-AI) resulted in a differential prioritization of 6.4% of patients within the first 90 days and would potentially save 1 in 59 deaths overall, and 1 in 13 deaths among women. Results did not substantially change when ascites was not included in the models. CONCLUSIONS: The use of explainable machine learning models may be preferred over conventional regression-based models for waiting list prioritization in LT. GEMA-AI made more accurate predictions of waiting list outcomes, particularly for the sickest patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computer Science and Numerical Analysis, University of Córdoba, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, Spain.
- Department of Hepatology and Liver Transplantation, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, Spain; Department of Medicine, University of Córdoba, Córdoba,…
- Department of Computer Science and Numerical Analysis, University of Córdoba, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, Spain; Department of Signal Processing and Communication…
- AW Morrow Gastroenterology and Liver Centre and Australian National Liver Transplant Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; Central Clinical School, University of Sydney, Sydney, New Sou…
- Department of Statistics and Clinical Studies, NHS Blood and Transplant, Stoke Gifford, United Kingdom.
- Sheila Sherlock Liver Unit and UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, United Kingdom. Electronic address: e.tsochatzis@ucl.ac.uk.
Förderung
- Consejería de Transformación Económica, Industria, Conocimiento y Universidades
- Agencia Estatal de Investigación
- European Regional Development Fund
- European Commission
- Universidad de Córdoba
- Spain Ministry of Science and Innovation
- Instituto de Salud Carlos III
- Ministerio de Universidades
Zitieren
APA
Gómez-Orellana, A. M., Rodríguez-Perálvarez, M. L., Guijo-Rubio, D., Gutiérrez, P. A., Majumdar, A., McCaughan, G. W., Taylor, R., Tsochatzis, E. A., & Hervás-Martínez, C. (2025). Gender-Equity Model for Liver Allocation Using Artificial Intelligence (GEMA-AI) for Waiting List Liver Transplant Prioritization. Clinical Gastroenterology and Hepatology, 23(12), 2187-2196. https://doi.org/10.1016/j.cgh.2024.12.010
Vancouver
Gómez-Orellana AM, Rodríguez-Perálvarez ML, Guijo-Rubio D, Gutiérrez PA, Majumdar A, McCaughan GW, et al. Gender-Equity Model for Liver Allocation Using Artificial Intelligence (GEMA-AI) for Waiting List Liver Transplant Prioritization. Clinical Gastroenterology and Hepatology. 2025;23(12):2187-2196. doi:10.1016/j.cgh.2024.12.010
BibTeX
@article{GmezOrellana2025,
author = {Gómez-Orellana, Antonio Manuel and Rodríguez-Perálvarez, Manuel Luis and Guijo-Rubio, David and Gutiérrez, Pedro Antonio and Majumdar, Avik and McCaughan, Geoffrey W and Taylor, Rhiannon and Tsochatzis, Emmanuel A and Hervás-Martínez, César},
title = {Gender-Equity Model for Liver Allocation Using Artificial Intelligence (GEMA-AI) for Waiting List Liver Transplant Prioritization},
journal = {Clinical Gastroenterology and Hepatology},
year = {2025},
volume = {23},
number = {12},
pages = {2187--2196},
doi = {10.1016/j.cgh.2024.12.010}
}
EUVIMED